(2E)-3-(3-chlorophenyl)-1-(2,5-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

N-Isopropyl-oxalamic acid, 95.0%, 1g

N-[3-(1H-imidazol-1-yl)propyl]-6-methoxy-1,3-benzothiazol-2-amine, 95.0%, 500mg

4-Bromo-1-tetrahydro-2H-pyran-4-yl-1H-pyrazole, 97.0%, 5g

2-Bromo-3-methylpyrazine, 95.0%, 250mg

4-(4-Bromophenyl)-1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid, 99.0%, 10g

Sample bags ROTILABO® with labelling area, 120 mm, Height, 170 mm, 100 Piece(s)

1-(2,2-Difluoroethyl)-1H-pyrazol-3-amine, 95%, 500mg

3-Chloro-5-nitro-2-pyridone>98.0%(T)1g

1-(Pyridin-3-ylmethyl)piperazine trihydrochloride, 95.0%, 1g

(1-(3-Chlorophenyl)cyclobutyl)methanamine, 95+%, 1g

(3-exo)-8-Oxobicyclo[3.2.1]octane-3-carboxylic acid, 98%, 500mg

3-Bromomethyl-3-methyloxetane, 97.0%, 25g